Celularity appoints Dr. Geoffrey Ling to board; Dr. von Eschenbach resigns

Celularity Inc

Dr. Andrew von Eschenbach resigned as Class I director effective August 31, 2023, not due to any disagreement.
Dr. Geoffrey Shiu Fei Ling appointed as Class I director to fill the vacancy, effective August 31, 2023.
Dr. Ling received a stock option for 1,250,000 shares at $0.324 exercise price, vesting over three years.
Dr. Ling brings >30 years experience in pharma, academia, DARPA, and military; retired U.S. Army colonel.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Geoffrey Shiu Fei Ling

Class I Director

CELU · Celularity Inc

Effective: 2023-08-31
Filed: September 7, 2023, 7:59 PM ET

the board appointed Geoffrey Shiu Fei Ling, M.D., as a Class I director to fill the vacancy left by the resignation of Dr. von Eschenbach, to serve until his successor is elected and qualified

Departed

Andrew C. von Eschenbach

Class I Director

CELU · Celularity Inc

Effective: 2023-08-31
Successor: Geoffrey Shiu Fei Ling
Filed: September 7, 2023, 7:59 PM ET

Andrew C. von Eschenbach, M.D., a Class I member of the board of directors of Celularity Inc., or Celularity, notified the board of directors of his intention to resign as a member of the board and all committees thereof effective August 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Geoffrey Shiu Fei Ling was appointed as Class I Director at Celularity Inc.

Action: appointed
Role: Class I Director

Exact text from the filing

the board appointed Geoffrey Shiu Fei Ling, M.D., as a Class I director to fill the vacancy left by the resignation of Dr. von Eschenbach, to serve until his successor is elected and qualified

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Andrew C. von Eschenbach resigned as Class I Director at Celularity Inc.

Action: resigned
Role: Class I Director

Exact text from the filing

Andrew C. von Eschenbach, M.D., a Class I member of the board of directors of Celularity Inc., or Celularity, notified the board of directors of his intention to resign as a member of the board and all committees thereof effective August 31, 2023.

View on SEC.gov

Celularity Inc filing history →

Source: SEC EDGAR

accession 0000950170-23-047017

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.